Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
6(40%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_4
3
20%
Ph phase_1
4
27%
Ph phase_3
4
27%
Ph phase_2
1
7%
Ph not_applicable
3
20%

Phase Distribution

4

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
4(26.7%)
Phase 2Efficacy & side effects
1(6.7%)
Phase 3Large-scale testing
4(26.7%)
Phase 4Post-market surveillance
3(20.0%)
N/ANon-phased studies
3(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

15

all time

Status Distribution
Active(8)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting5
unknown2
Enrolling by invitation1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
6
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (26.7%)
Phase 21 (6.7%)
Phase 34 (26.7%)
Phase 43 (20.0%)
N/A3 (20.0%)

Trials by Status

completed533%
enrolling_by_invitation17%
recruiting533%
unknown213%
active_not_recruiting17%
not_yet_recruiting17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07440069Phase 4

Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor

Recruiting
NCT04998188Not Applicable

Hydrolyzed Collagen Formulation vs Placebo in Knee Osteoarthritis

Recruiting
NCT07272434Phase 3

Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)

Recruiting
NCT06040203Not Applicable

Leukocyte-rich PRP or Leukocyte-free PRP vs Placebo in the Treatment of Epicondylitis

Recruiting
NCT07010926Phase 2

A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease

Not Yet Recruiting
NCT06642558Phase 1

Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above

Active Not Recruiting
NCT05964868Phase 3

Efficacy of Liposomal Bupivacaine Post Septorhinoplasty

Enrolling By Invitation
NCT05528328Phase 3

Post-surgical Scars After the Use of CACIPLIQ20

Recruiting
NCT03814590Phase 1

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

Completed
NCT02435732Phase 1

CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60%

Unknown
NCT03759301Phase 4

Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders

Completed
NCT00915967Not Applicable

Prevention of Neurosurgical Wound Infections

Completed
NCT02074358Phase 1

A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects

Completed
NCT02299908Phase 4

Ultrasound-guided Transverses Abdominis Plane Block in Inguinal Herniorrhaphy: Randomized Controlled Clinical Trial

Unknown
NCT01268761Phase 3

GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome

Completed

All 15 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
15